Oppenheimer & Co’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$78.2K Buy
+11,500
New +$90.7K ﹤0.01% 1718

Other funds holding KYTX

Oppenheimer & Co's KYTX Position: Q3 2026 in Review

Oppenheimer & Co opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 11,500 shares worth $78.2K. The stake represents ﹤0.01% of the portfolio and ranks #1718 among its holdings.

128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • Oppenheimer & Co held 11,500 shares of Kyverna Therapeutics worth $78.2K as of Q3 2026.
  • Kyverna Therapeutics was a new Oppenheimer & Co position in Q3 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Oppenheimer & Co's portfolio in Q3 2026, its #1718 holding.
  • 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.